Quality of life in women with migraine: a systematic review

Adriana de Almeida Soares; Yasmine Maria Leódido Fortes; Wallyson Pablo de Oliveira Souza; Raimundo Pereira Silva-Néto

Quality of life in women with migraine: a systematic review

Views: 17

Autores

Adriana de Almeida Soares Federal University of the Parnaíba Delta https://orcid.org/0000-0001-7002-6458
Yasmine Maria Leódido Fortes Federal University of the Parnaíba Delta https://orcid.org/0000-0001-9642-0330
Wallyson Pablo de Oliveira Souza Federal University of the Parnaíba Delta https://orcid.org/0000-0003-3122-9484
Raimundo Pereira Silva-Néto Federal University of the Parnaíba Delta, Parnaíba, Brazil. https://orcid.org/0000-0002-2343-9679

Palavras-chave:

Quality of life, Pain, Migraine in women, Treatment

Resumo

Introdução: Diversas doenças crônicas interferem na qualidade de vida (QV), entre elas a migrânea, principalmente em mulheres que são as mais acometidas. Entretanto, intervenções terapêuticas eficazes são capazes de modificar a doença. Objetivo: Nosso objetivo foi revisar a literatura sobre QV em mulheres com migrânea, antes e após o tratamento. Métodos: Este estudo foi uma revisão sistemática de ensaios clínicos sobre migrânea em mulheres e QV publicados entre novembro de 2019 e outubro de 2024. A pesquisa foi realizada na base de dados online PubMed, utilizando os descritores “migraine in women” e “quality of life”. Resultados: Foram analisados oito artigos. Eles descreveram 1.337 mulheres com migrânea com idade entre 18 e 50 anos. Houve melhora na QV após intervenção terapêutica, tanto medicamentosa quanto não medicamentosa. Conclusões: Mulheres com migrânea têm sua QV prejudicada, mas intervenções terapêuticas podem modificar a doença.

Downloads

Não há dados estatísticos.

Referências

Kluthcovsky ACGC, Takayanagui AMM. Qualidade de vida: aspectos conceituais. Revista Salus. 2007;1(1):13–15.

The WHOQOL Group. The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;41(10):1403–10. DOI: 10.1016/0277-9536(95)00112-k.

Felce D, Perry J. Quality of life: its definition and measurement. Res Dev Disabil. 1995;16(1):51–74. DOI: 10.1016/0891-4222(94)00028-8.

Sanvito WL, Monzillo, P.H. O livro das cefaleias. São Paulo: Atheneu, 2001.

Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211. DOI: 10.1177/0333102417738202.

Queiroz LP, Peres MFP, Piovesan EJ, Kowacs F, Ciciarelli MC, Souza JA, et al. A nationwide population-based study of migraine in Brazil. Cephalalgia. 2009;29(6):642–9. DOI: 10.1111/j.1468-2982.2008.01782.x.

Steiner TJ, Stovner LJ, Vos T, Jensen R, Katsarava Z. Migraine is first cause of disability in under 50s: Will health politicians now take notice? J Headache Pain. 2018;19(1):17. DOI: 10.1186/s10194-018-0846-2.

MacGregor EA, Okonkwo R, Detke HC, Polavieja P, Fernandes MS, Pavlovic JM. Effect of galcanezumab in women with episodic migraine meeting criteria for menstrually related migraine: a post hoc analysis of EVOLVE-1 and EVOLVE-2. Headache. 2024;64(2):179–87. DOI: 10.1111/head.14652.

Arab A, Khorvash F, Kazemi M, Heidari Z, Askari G. Effects of the dietary approaches to stop hypertension (DASH) diet on clinical, quality of life and mental health outcomes in women with migraine: a randomized controlled trial. Br J Nutr. 2022;128(8):1535–44. DOI: 10.1017/S000711452100444X.

Vajdi M, Khorvash F, Askari G. A randomized, double-blind, placebo-controlled parallel trial to test the effect of inulin supplementation on migraine headache characteristics, quality of life and mental health symptoms in women with migraine. Food Funct. 2024;15(19):10088–98. DOI: 10.1039/d4fo02796e.

Babapour M, Khorvash F, Rouhani MH, Ghavami A, Ghasemi-Tehrani H, Heidari Z, et al. Effect of soy isoflavones supplementation on migraine characteristics, mental status and calcitonin gene-related peptide (CGRP) levels in women with migraine: results of randomized controlled trial. Nutr J. 2022;21(1):50. DOI: 10.1186/s12937-022-00802-z.

Celenay ST, Coban O, Mete O, Karahan N. An investigation of the effects of connective tissue massage in women with migraine: a controlled clinical trial. J Bodyw Mov Ther. 2023;33:112–9. DOI: 10.1016/j.jbmt.2022.09.008.

Dzator JSA, Howe PRC, Coupland KG, Wong RHX. A randomized, double-blind, placebo-controlled crossover trial of resveratrol supplementation for prophylaxis of hormonal migraine. Nutrients. 2022;14(9):1763. DOI: 10.3390/nu14091763.

Luo W, Cao X, Zhao J, Yang J, Cen Y, He J, et al. Health-related quality of life and associated factors in Chinese menstrual migraine patients: a cross-sectional study. BMC Womens Health. 2022;22(1):177. DOI: 10.1186/s12905-022-01760-8.

Disease GBD, Injury I, Prevalence C. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–59. DOI. 10.1016/S0140-6736(17)32154-2.

Weatherall MW. The diagnosis and treatment of chronic migraine. Ther Adv Chronic Dis. 2015;6(3):115–23. DOI: 10.1177/2040622315579627.

Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the United States: updated age, sex, and socioeconomic-specific estimates from government health surveys. Headache. 2021;61(1):60–8. DOI: 10.1111/head.14024.

Muñoz Gómez E, Aguilar Rodríguez M, Serra Añó P, Sempere Rubio N, Mollà Casanova S, Inglés M. Sex-related differences in migraine clinical features by frequency of occurrence: a cross-sectional study. Scand J Pain. 2023;23(3):553–62. DOI: 10.1515/sjpain-2022-0152.

Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343–9. DOI. 10.1212/01.wnl.0000252808.97649.21.

Agosti R. Migraine Burden of Disease: From the Patient's Experience to a Socio-Economic View. Headache. 2018:58 Suppl 1:17–32. DOI: 10.1111/head.13301.

Merikangas KR, Cui L, Richardson AK, Isler H, Khoromi S, Nakamura E, et al. Magnitude, impact, and stability of primary headache subtypes: 30-year prospective Swiss cohort study. BMJ. 2011:343:d5076. DOI: 10.1136/bmj.d5076.

Ramsden CE, Zamora D, Faurot KR, Maclntosh B, Horowitz M, Keyes GS, et al. Dietary alteration of n-3 and n-6 fatty acids for headache reduction in adults with migraine: randomized controlled trial. BMJ. 2021:374:n1448. DOI: 10.1136/bmj.n1448.

Melhado EM, Santos PSF, Kaup AO, Costa ATNM, Roesler ACP, Piovesan EJ, et al. Consensus of the Brazilian Headache Society (SBCe) for the prophylactic treatment of episodic migraine: part I. Arq Neuropsiquiatr. 2022;80(8):845–61. DOI: 10.1055/s-0042-1756441.

Kowacs F, Roesler CAP, Piovesan EJ, Sarmento EM, Campos HC, Maciel Jr JA, et al. Consensus of the Brazilian Headache Society on the treatment of chronic migraine. Arq Neuropsiquiatr. 2019;77(7):509–20. DOI: 10.1590/0004-282X20190078.

Downloads

PDF (English)

Publicado

2024-12-30

Como Citar

Soares A de A, Fortes YML, Souza WP de O, Silva-Néto RP. Quality of life in women with migraine: a systematic review. Headache Med [Internet]. 30º de dezembro de 2024 [citado 8º de janeiro de 2025];15(4). Disponível em: https://headachemedicine.com.br/index.php/hm/article/view/1323